We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome

This study has been withdrawn prior to enrollment.
(The FDA IND application is paused due to additional required testing. The IRB protocol was closed prior to research starting.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00855972
First Posted: March 5, 2009
Last Update Posted: December 11, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Sean Mackey, Stanford University
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)